ACLX
Price
$53.62
Change
+$0.83 (+1.57%)
Updated
May 17, 6:59 PM EST
85 days until earnings call
PDSB
Price
$3.49
Change
-$0.04 (-1.13%)
Updated
May 17, 6:59 PM EST
87 days until earnings call
Ad is loading...

ACLX vs PDSB

Header iconACLX vs PDSB Comparison
Open Charts ACLX vs PDSBBanner chart's image
Arcellx
Price$53.62
Change+$0.83 (+1.57%)
Volume$234.81K
CapitalizationN/A
PDS Biotechnology
Price$3.49
Change-$0.04 (-1.13%)
Volume$161.88K
CapitalizationN/A
View a ticker or compare two or three
ACLX vs PDSB Comparison Chart

Loading...

ACLXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PDSBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACLX vs. PDSB commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and PDSB is a Hold.

COMPARISON
Comparison
May 19, 2024
Stock price -- (ACLX: $53.62 vs. PDSB: $3.49)
Brand notoriety: ACLX and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 95% vs. PDSB: 28%
Market capitalization -- ACLX: $2.87B vs. PDSB: $128.01M
ACLX [@Biotechnology] is valued at $2.87B. PDSB’s [@Biotechnology] market capitalization is $128.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whilePDSB’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • PDSB’s FA Score: 0 green, 5 red.
According to our system of comparison, PDSB is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 5 TA indicator(s) are bullish while PDSB’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 5 bullish, 2 bearish.
  • PDSB’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, both ACLX and PDSB are a good buy in the short-term.

Price Growth

ACLX (@Biotechnology) experienced а +7.80% price change this week, while PDSB (@Biotechnology) price change was -0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 12, 2024.

PDSB is expected to report earnings on Aug 14, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACLX with price predictions.
OPEN
A.I.dvisor published
a Summary for PDSB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ACLX($2.87B) has a higher market cap than PDSB($128M). ACLX YTD gains are higher at: -3.387 vs. PDSB (-29.779).
ACLXPDSBACLX / PDSB
Capitalization2.87B128M2,241%
EBITDAN/AN/A-
Gain YTD-3.387-29.77911%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXPDSB
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
77%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
ACLXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PDSBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ERLGX18.530.05
+0.27%
Eaton Vance Atlanta Capital Fcs Gr R6
PCMVX17.660.03
+0.17%
Principal MidCap Value I A
SSEYX484.280.59
+0.12%
State Street Equity 500 Index II
TBLRX12.53-0.01
-0.08%
Transamerica Balanced II R
PEMLX13.81-0.03
-0.22%
Putnam Emerging Markets Equity R

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with ALLO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+1.57%
ALLO - ACLX
44%
Loosely correlated
-7.97%
NTLA - ACLX
43%
Loosely correlated
+0.19%
VRDN - ACLX
42%
Loosely correlated
-8.07%
XNCR - ACLX
41%
Loosely correlated
+2.54%
BEAM - ACLX
41%
Loosely correlated
+3.49%
More

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-1.13%
AXON - PDSB
43%
Loosely correlated
-0.57%
MDGL - PDSB
38%
Loosely correlated
+1.33%
MNKD - PDSB
36%
Loosely correlated
N/A
INZY - PDSB
35%
Loosely correlated
-2.75%
ACLX - PDSB
35%
Loosely correlated
+1.57%
More